Identification of germline variants in adults with hemophagocytic lymphohistiocytosis
- PMID: 32150605
- PMCID: PMC7065469
- DOI: 10.1182/bloodadvances.2019001272
Identification of germline variants in adults with hemophagocytic lymphohistiocytosis
Abstract
Some germline variants are predicted to disrupt protein function in HLH-associated genes.
Such variants are neither enriched in adult-onset HLH nor associated with specific clinical or laboratory features of HLH.
Conflict of interest statement
Conflict-of-interest disclosure: B.L.E. has received research funding from Celgene and Deerfield, consulting fees from GRAIL, and is on the scientific advisory boards for Exo Therapeutics and Skyhawk Therapeutics. P.G.M. has received consulting fees from Foundation Medicine, Inc. The remaining authors declare no competing financial interests.
Figures
References
-
- Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908-2914. - PubMed
-
- Brisse E, Wouters CH, Matthys P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br J Haematol. 2016;174(2):203-217. - PubMed
